TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 131 filers reported holding TRICIDA INC in Q3 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $162,010 | -96.4% | 1,059,582 | +148.2% | 0.00% | -93.3% |
| Q3 2022 | $4,475,000 | +31.9% | 426,964 | +21.8% | 0.02% | +36.4% |
| Q2 2022 | $3,394,000 | +19.5% | 350,599 | +1.5% | 0.01% | +37.5% |
| Q1 2022 | $2,840,000 | -19.1% | 345,460 | -6.0% | 0.01% | 0.0% |
| Q4 2021 | $3,512,000 | +454.8% | 367,390 | +169.5% | 0.01% | +700.0% |
| Q3 2021 | $633,000 | -64.1% | 136,324 | -66.6% | 0.00% | -75.0% |
| Q2 2021 | $1,763,000 | -54.9% | 408,217 | -44.8% | 0.00% | -60.0% |
| Q1 2021 | $3,909,000 | +94.1% | 738,949 | +158.7% | 0.01% | +66.7% |
| Q4 2020 | $2,014,000 | +30.8% | 285,607 | +68.0% | 0.01% | +20.0% |
| Q3 2020 | $1,540,000 | -68.9% | 169,959 | -5.6% | 0.01% | -79.2% |
| Q2 2020 | $4,946,000 | +144.2% | 179,981 | +95.6% | 0.02% | +50.0% |
| Q1 2020 | $2,025,000 | +23.2% | 92,029 | +111.3% | 0.02% | +220.0% |
| Q4 2019 | $1,644,000 | +7.5% | 43,552 | -12.1% | 0.01% | 0.0% |
| Q3 2019 | $1,530,000 | – | 49,566 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |